They all manifest MSI within their cancers, and immunohistochemistry detects abnormal DNA MMR protein—not only for MLH1 but also for the main DNA MMR proteins, including MSH2, MSH6, and PMS2, as with true Lynch syndrome cancers [53]. The gene discussed is PMS2; the disease is Lynch syndrome.